Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Luzza

Showing results (131-140 of 159) with videos related to

Pageof 16
Sort By:
Minerva Medica|February 15, 2022
Evaluation of serum calprotectin as novel biomarker in psoriatic patients: a prospective pilot studyElisabetta Scali, Stefano Dastoli, Anna C Procopio, et al.
Minerva Medica|April 28, 2020
Critical review on the use and abuse of alcohol. When the dose makes the differenceRosa Di Sarno, Annalisa Brigida, Giuseppe G Caprio, et al.
Medicine and Pharmacy Reports|August 25, 2021
Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case seriesTiziana Larussa, Antonio Basile, Caterina Palleria, et al.
Medicina (Kaunas, Lithuania)|August 8, 2019
Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease PatientsDavide Giuseppe Ribaldone, Alessandro Adriani, Gian Paolo Caviglia, et al.
Pharmaceutics|November 26, 2022
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance StudyMartina Tallarico, Caterina Palleria, Livia Ruffolo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 9, 2015
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015Rocco Maurizio Zagari, Marco Romano, Veronica Ojetti, et al.
Sensors (Basel, Switzerland)|March 30, 2023
The r'-Wave Algorithm: A New Diagnostic Tool to Predict the Diagnosis of Brugada Syndrome after a Sodium Channel Blocker Provocation TestGiampaolo Vetta, Antonio Parlavecchio, Lorenzo Pistelli, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|September 19, 2017
Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases CentersAntonio Tursi, Leonardo Allegretta, Nello Buccianti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 21, 2026
Development and validation of the IBD frailty score in a multicenter prospective cohort of IBD outpatientsSilvia Salvatori, Chiara Venuto, Diana Giannarelli, et al.
Annals of Gastroenterology|July 3, 2019
Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centersAntonio Tursi, Giammarco Mocci, Roberto Faggiani, et al.
Pageof 16

Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
Minerva Medica|February 15, 2022
Evaluation of serum calprotectin as novel biomarker in psoriatic patients: a prospective pilot studyElisabetta Scali, Stefano Dastoli, Anna C Procopio, et al.
Minerva Medica|April 28, 2020
Critical review on the use and abuse of alcohol. When the dose makes the differenceRosa Di Sarno, Annalisa Brigida, Giuseppe G Caprio, et al.
Medicine and Pharmacy Reports|August 25, 2021
Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case seriesTiziana Larussa, Antonio Basile, Caterina Palleria, et al.
Medicina (Kaunas, Lithuania)|August 8, 2019
Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease PatientsDavide Giuseppe Ribaldone, Alessandro Adriani, Gian Paolo Caviglia, et al.
Pharmaceutics|November 26, 2022
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance StudyMartina Tallarico, Caterina Palleria, Livia Ruffolo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 9, 2015
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015Rocco Maurizio Zagari, Marco Romano, Veronica Ojetti, et al.
Sensors (Basel, Switzerland)|March 30, 2023
The r'-Wave Algorithm: A New Diagnostic Tool to Predict the Diagnosis of Brugada Syndrome after a Sodium Channel Blocker Provocation TestGiampaolo Vetta, Antonio Parlavecchio, Lorenzo Pistelli, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|September 19, 2017
Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases CentersAntonio Tursi, Leonardo Allegretta, Nello Buccianti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 21, 2026
Development and validation of the IBD frailty score in a multicenter prospective cohort of IBD outpatientsSilvia Salvatori, Chiara Venuto, Diana Giannarelli, et al.
Annals of Gastroenterology|July 3, 2019
Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centersAntonio Tursi, Giammarco Mocci, Roberto Faggiani, et al.
Pageof 16